Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07187297 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later across 2 updates Jun 2026 → Feb 2027
See other at-risk trials from Bausch Health Americas, Inc.

Record History

  1. Primary completion pushed from Sep 2026 to Feb 2027 Primary completion pushed from Jun 2026 to Sep 2026 · Trial sites expanded: 1 → 7 locationsv6 Show 2 more changesShow less
    • Primary completion pushed from Jun 2026 to Sep 2026
    • Trial sites expanded: 1 → 7 locations
  2. Study sites: 1 to 7 Primary completion date: Jun 2026 to Sep 2026v5 Show 1 more changeShow less
    • Primary completion date: Jun 2026 to Sep 2026
  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 2025 to Oct 31, 2025 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Oct 2025 to Oct 31, 2025
    • Site details revised
  4. Site contact updatedv3
  5. Study title shortened, about 20 wordsv2 See this version in full on ClinicalTrials.gov ↗
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System
Trial Details
NCT Number NCT07187297
Lead Sponsor Bausch Health Americas, Inc.
Conditions Wrinkle, Lax Skin, Lines Skin
Enrollment 164 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov